FI964045L - CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä - Google Patents

CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä Download PDF

Info

Publication number
FI964045L
FI964045L FI964045A FI964045A FI964045L FI 964045 L FI964045 L FI 964045L FI 964045 A FI964045 A FI 964045A FI 964045 A FI964045 A FI 964045A FI 964045 L FI964045 L FI 964045L
Authority
FI
Finland
Prior art keywords
gastrin
cck
benzodiazepines
heterocyclic
regulating
Prior art date
Application number
FI964045A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI964045A7 (fi
FI964045A0 (fi
Inventor
Christopher Joseph Aquino
Elizabeth Ellen Sugg
Jerzy Ryszard Szewczyk
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9407433A external-priority patent/GB9407433D0/en
Priority claimed from GB9420783A external-priority patent/GB9420783D0/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of FI964045A7 publication Critical patent/FI964045A7/fi
Publication of FI964045A0 publication Critical patent/FI964045A0/fi
Publication of FI964045L publication Critical patent/FI964045L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI964045A 1994-04-14 1995-04-12 CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä FI964045L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9407433A GB9407433D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivatives
GB9420783A GB9420783D0 (en) 1994-10-14 1994-10-14 Heterocyclic derivatives
PCT/US1995/004163 WO1995028419A1 (en) 1994-04-14 1995-04-12 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines

Publications (3)

Publication Number Publication Date
FI964045A7 FI964045A7 (fi) 1996-10-09
FI964045A0 FI964045A0 (fi) 1996-10-09
FI964045L true FI964045L (fi) 1996-10-09

Family

ID=26304703

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964045A FI964045L (fi) 1994-04-14 1995-04-12 CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä

Country Status (25)

Country Link
EP (1) EP0756602B1 (de)
JP (1) JPH09511223A (de)
KR (1) KR970702274A (de)
CN (1) CN1176646A (de)
AT (1) ATE181737T1 (de)
AU (1) AU697349B2 (de)
BR (1) BR9507381A (de)
CA (1) CA2186900A1 (de)
CZ (1) CZ286764B6 (de)
DE (1) DE69510545T2 (de)
DK (1) DK0756602T3 (de)
ES (1) ES2135722T3 (de)
FI (1) FI964045L (de)
GR (1) GR3031335T3 (de)
HU (1) HUT76135A (de)
IL (1) IL113365A (de)
IS (1) IS4367A (de)
MX (1) MX9604765A (de)
NO (1) NO964348L (de)
NZ (1) NZ283929A (de)
PL (1) PL180026B1 (de)
RU (1) RU2152939C1 (de)
SK (1) SK281433B6 (de)
TW (1) TW369529B (de)
WO (1) WO1995028419A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
ES2206754T3 (es) * 1996-12-10 2004-05-16 Zeria Pharmaceutical Co., Ltd. Derivados de 1,5 - benzodiazepina.
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
EP1123928A4 (de) * 1998-10-20 2005-02-16 Takeda Pharmaceutical 1,5-benzodiazepin-verbindungen, verfahren zu ihrer herstellung und eine medizin
JP4535350B2 (ja) * 1998-11-17 2010-09-01 クミアイ化学工業株式会社 ピリミジニルベンズイミダゾール誘導体及び農園芸用殺菌剤
ATE402700T1 (de) * 2002-08-27 2008-08-15 Merck Patent Gmbh Glycinamid-derivate als raf-kinase-hemmer
EA010888B1 (ru) 2004-05-25 2008-12-30 Пфайзер Продактс, Инк. Тетраазабензо[е]азуленовые производные и их аналоги
RU2303597C1 (ru) * 2006-05-12 2007-07-27 Иващенко Андрей Александрович Фармацевтическая композиция, способы ее получения и применения
EP2803662B1 (de) 2012-01-13 2017-03-01 Nippon Chemiphar Co., Ltd. P2x4-rezeptor-antagonisten
SG10201913587WA (en) 2016-02-05 2020-02-27 Denali Therapeutics Inc Inhibitors of receptor-interacting protein kinase 1
DK3552017T3 (da) 2016-12-09 2022-05-16 Denali Therapeutics Inc Forbindelser, der er anvendelige som ripk1-inhibitorer
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119
CA3173731A1 (en) 2020-02-28 2021-09-02 Kallyope, Inc. Gpr40 agonists
WO2023137035A1 (en) 2022-01-12 2023-07-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
SK130096A3 (en) 1997-08-06
NO964348L (no) 1996-12-02
BR9507381A (pt) 1997-09-23
RU2152939C1 (ru) 2000-07-20
CN1176646A (zh) 1998-03-18
NO964348D0 (no) 1996-10-11
CA2186900A1 (en) 1995-10-26
HU9602835D0 (en) 1996-12-30
FI964045A7 (fi) 1996-10-09
WO1995028419A1 (en) 1995-10-26
ATE181737T1 (de) 1999-07-15
ES2135722T3 (es) 1999-11-01
DE69510545T2 (de) 2000-01-13
PL316870A1 (en) 1997-02-17
DK0756602T3 (da) 2000-01-31
JPH09511223A (ja) 1997-11-11
TW369529B (en) 1999-09-11
CZ297296A3 (en) 1997-09-17
AU697349B2 (en) 1998-10-01
IL113365A (en) 1999-11-30
IL113365A0 (en) 1995-07-31
KR970702274A (ko) 1997-05-13
EP0756602A1 (de) 1997-02-05
GR3031335T3 (en) 1999-12-31
FI964045A0 (fi) 1996-10-09
DE69510545D1 (de) 1999-08-05
MX9604765A (es) 1998-05-31
SK281433B6 (sk) 2001-03-12
EP0756602B1 (de) 1999-06-30
IS4367A (is) 1996-09-30
CZ286764B6 (en) 2000-06-14
NZ283929A (en) 1998-02-26
PL180026B1 (pl) 2000-12-29
AU2239095A (en) 1995-11-10
HUT76135A (en) 1997-06-30

Similar Documents

Publication Publication Date Title
TR199501724A2 (tr) Sizdirmazlik saglayici düzen.
NO970174D0 (no) 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
DE69613286D1 (de) Elektroplattierungsverfahren
DE69700667D1 (de) Elektroplattierungsverfahren
DE69802367D1 (de) Plattierungsverfahren
TR199501528A1 (tr) Pirol türevleri.
DE69630414D1 (de) 5B4T-Kodierungsschema
FI964045A7 (fi) CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä
DE69832845D1 (de) Elektroplattierungsverfahren
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
DK0915189T3 (da) Elektropletteringsapparat
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
TR28915A (tr) Naftokinon türevleri.
DE69737975D1 (de) Aussenbordmotor
DE69713849D1 (de) Elektroplattierungsverfahren
ES1032571Y (es) Gafa,
FI953624A0 (fi) Puhelimen luuri tai käsipuhelinkoje
ES1031990Y (es) Inductor ecolo-magnetico.
NO942127D0 (no) Underbenklær
FI950956A0 (fi) Luftkabel, saosom haengspiralkabel
FI952416A0 (fi) Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor
FI952912A0 (fi) Traedcylinder, gripelement med traedrotsprincip
FI944648A0 (fi) Bromsmekanism foer fordon, saerskilt foer en cykel
FIU940180U0 (fi) Baotstege, kaerra, landgaong